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Abstract
An increased intestinal permeability is associated with several diseases. Previously, we have shown that dietary Ca decreases colonic
permeability in rats. This might be explained by a calcium-phosphate-induced increase in luminal buffering capacity, which protects
against an acidic pH due to microbial fermentation. Therefore, we investigated whether dietary phosphate is a co-player in the effect
of Ca on permeability. Rats were fed a humanised low-Ca diet, or a similar diet supplemented with Ca and containing either high,
medium or low phosphate concentrations. Chromium-EDTA was added as an inert dietary intestinal permeability marker. After dietary
adaptation, short-chain fructo-oligosaccharides (scFOS) were added to all diets to stimulate fermentation, acidify the colonic contents
and induce an increase in permeability. Dietary Ca prevented the scFOS-induced increase in intestinal permeability in rats fed medium-
and high-phosphate diets but not in those fed the low-phosphate diet. This was associated with higher faecal water cytotoxicity and
higher caecal lactate levels in the latter group. Moreover, food intake and body weight during scFOS supplementation were adversely
affected by the low-phosphate diet. Importantly, luminal buffering capacity was higher in rats fed the medium- and high-phosphate
diets compared with those fed the low-phosphate diet. The protective effect of dietary Ca on intestinal permeability is impaired if dietary
phosphate is low. This is associated with a calcium phosphate-induced increase in luminal buffering capacity. Dragging phosphate into the
colon and thereby increasing the colonic phosphate concentration is at least part of the mechanism behind the protective effect of Ca on
intestinal permeability.
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The intestinal tract is lined by a monolayer of epithelial cells,
which is the largest and most important barrier between the
body’s internal milieu and the hostile external environment.
Tight contact between the epithelial cells prevents access of
luminal digestive enzymes, toxins, antigens and enteric micro-
biota to underlying tissue compartments(1–3). Intestinal barrier
dysfunction is suggested to be associated with the pathogen-
esis of a variety of intestinal diseases, including inflammatory
bowel disease, coeliac disease, post-infectious irritable bowel
syndrome and food allergy(1–5).
Interestingly, dietary components can influence the epi-
thelial barrier, in particular intestinal permeability, and hence
possibly modulate disease development. We are interested in
the effect of dietary Ca, since it has been shown in several
controlled studies that Ca is important for protection against
intestinal infections with food-borne bacterial pathogens,
both in rats and in human subjects(6–9). In addition, Ca
displayed cytoprotective effects in several studies in the field
of colon carcinogenesis by precipitating cytotoxic surfactants,
such as secondary bile acids(10,11). Furthermore, supplemental
Ca attenuated the development of colitis in HLA-B27 trans-
genic rats, which was associated with the prevention of a
colitis-related increase in intestinal permeability due to
Ca(12). In a previous study(13), we identified that the effect of
dietary Ca on intestinal permeability is located in the colon.
At present, however, it is still not clear how Ca exerts its
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protective effect on colonic permeability. Upon dietary
intake, an insoluble calcium phosphate complex is formed
in the small intestine, both in rats(14) and in humans(15). In
this way, Ca prevents phosphate from being absorbed in the
small intestine, and drags phosphate into the colon. In the
colon, solubilisation of this complex increases the buffering
capacity of the luminal contents, which protects the intestinal
mucosa from being injured by an acidic pH due to microbial
fermentation(16). This mechanism might play a role in the
effect of Ca on intestinal permeability, and it implies that diet-
ary phosphate intake might be of importance for the effect of
Ca on permeability.
In the present study, we investigated the potential effect of
dietary phosphate on Ca-induced lowering of intestinal
permeability, by applying high, medium or low phosphate
concentrations in a high-Ca diet. Inert chromium-EDTA
(CrEDTA) was added to the diets as an established marker
for intestinal permeability(17,18). After dietary adaptation for
10 d, short-chain fructo-oligosaccharides (scFOS) were intro-
duced in the diets. The intestinal fermentation of scFOS
leads to a luminal organic acid load, which challenges the buf-
fering capacity. We hypothesise that intestinal permeability
will increase on a high-Ca diet with concomitant low dietary
phosphate levels because of a decreased buffering capacity.
Materials and methods
Experimental design: animals and diets
The experimental protocol was approved by the animal wel-
fare committee of Wageningen University and Research
Centre (Wageningen, The Netherlands). Specific pathogen-
free outbred male Wistar rats (WU; Harlan, Horst, The
Netherlands), 8 weeks old and with a mean body weight of
288 g at the start of the experiment, were housed individually
in metabolic cages. Animals were kept in a temperature- and
humidity-controlled environment in a 12 h light–12 h dark
cycle. Rats (ten animals per dietary group) were fed a purified
‘humanised’ Western diet in restricted quantities (16 g/d).
Restricted feeding was necessary to prevent scFOS-induced
differences in food consumption as observed earlier(19) and
hence differences in vitamin, mineral and CrEDTA intake.
Demineralised drinking-water was supplied ad libitum. The
reference diet (low-Ca, medium-phosphate; LCaMP), which
has been used as a reference diet in our previous exper-
iments(12,13), contained (per kg): 200 g acid casein, 326 g
maize starch, 172 g glucose, 160 g palm oil, 40 g maize oil, 50 g
cellulose, 2 g CrEDTA (see below) and 5·16 g CaHPO4.2H2O
(corresponding to 30 mmol Ca/kg diet; Sigma-Aldrich, St
Louis, MO, USA). Vitamins and minerals (other than Ca)
were added to the diets according to AIN-93(20). The concen-
tration of vitamins and minerals was increased by 20 % to
ensure adequate intake during restricted feeding. The diets
had a high fat content to mimic the composition of a Western
human diet. Dietary phosphate mainly originates from calcium
phosphate and the protein source of the diet (casein: about
40 mmol phosphate/kg diet). The experimental diets were
supplemented with 90 mmol CaHPO4.2H2O/kg diet (high-Ca,
high-phosphate; HCaHP), or with 90 mmol CaCl2.2H2O/kg
diet (high-Ca, medium-phosphate; HCaMP), at the expense
of glucose. The high-Ca, low-phosphate diet (HCaLP) was
supplemented with 90 mmol CaCl2.2H2O/kg diet, and the
casein of this diet was replaced by whey protein isolate as a
low-phosphate protein source (BiPRO, about 5 mmol phos-
phate/kg diet; Davisco Foods International, Inc., Eden Prairie,
MN, USA). Thus, the experiment consisted of four different
diets: LCaMP diet (reference diet; 30 mmol Ca and 70 mmol
phosphate/kg diet), HCaHP diet (positive control since this
diet has been used in our previous experiments, showing
the effects of Ca on intestinal permeability(12,13); 120 mmol
Ca and 160 mmol phosphate/kg diet), HCaMP diet
(120 mmol Ca and 70 mmol phosphate/kg diet) and HCaLP
diet (120 mmol Ca and 35 mmol phosphate/kg diet). Inert
CrEDTA was added to all diets to quantify intestinal per-
meability(18). CrEDTA solution was prepared as described
elsewhere and subsequently freeze-dried(21). To check the
complete formation and stability of the CrEDTA complex,
the prepared CrEDTA solution was passed through a cation-
exchange resin column (Chelex 100 Resin; Bio-Rad, Hercules,
CA, USA). No uncomplexed Cr3þ ions were present. Rats were
fed the experimental diets for 10 d, after which all diets were
supplemented with 60 g scFOS/kg diet (6 %, w/w; Raftilosew
P95; Orafti, Tienen, Belgium) at the expense of glucose.
Food intake was recorded daily and animal weight twice
every week. At experimental day 20, rats were anaesthetised
with isoflurane and killed. The caecum was excised and
caecal contents were collected.
Measurement of intestinal permeability
Total 24 h urine samples were collected at experimental days
10 and 20. For the CrEDTA measurement, urine was acidified
with 50 g TCA/l, centrifuged for 2 min at 14 000 g and the
supernatant was subsequently diluted with 0·5 g CsCl/l.
Then, chromium was analysed by inductively coupled
plasma-atomic emission spectrophotometry.
Analyses of faeces and caecal contents
All faeces were collected during the last 3 d of experimental
feeding without scFOS (pre-scFOS; experimental days 8, 9
and 10), and during the last 3 d of the scFOS supplementation
period (experimental days 18, 19 and 20). Faeces and caecal
contents were freeze-dried and subsequently ground to
obtain homogeneous powdered samples. Ca and P were
quantified in the faeces of the pre-scFOS period. To this
end, faeces were treated with 50 g TCA/l, centrifuged for
2 min at 14 000g, diluted with 0·5 g CsCl/l, and analysed by
inductively coupled plasma-atomic emission spectropho-
tometry. Buffering capacity was also determined in the
faeces of the pre-scFOS period. To this end, pools of the
freeze-dried faeces (2 g) were reconstituted with double-
distilled water to 15 % dry weight. The quantities of hydrochloric
acid required to decrease the pH to 5 in these samples were
measured, as described earlier(16). For the cytotoxicity assay,
faecal water was prepared by reconstituting freeze-dried
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faeces with double-distilled water to 25 % dry weight as
described previously(22). The cytotoxicity of the faecal water
of the scFOS supplementation period was determined by
potassium release of a human erythrocyte suspension after
incubation with faecal water, as described earlier(23), and
validated earlier with intestinal epithelial cells(24). Cytotoxicity
was calculated and is expressed as a percentage of maximal
lysis. Total lactic acid was determined in caecal contents
using a colorimetric enzymatic kit (Enzyplus; BioControl
Systems, Inc., Bellevue, WA, USA), as described earlier(25).
Statistical analysis
All results are expressed as mean values with their standard
errors. The predefined comparisons of interest were the
LCaMP diet v. the HCaHP diet to study the effect of Ca (these
two diets have been compared in our previous studies, showing
the effects of Ca on intestinal permeability(12,13)), and the
HCaHP diet v. the HCaMP diet and the HCaMP diet v. the
HCaLP diet to study the effects of phosphate. Statistics were
done by using one-way ANOVA or Kruskal–Wallis test, depend-
ing on the normality of the data. If differences were significant,
this was followed by Student’s t test (for normally distributed
data) or Mann–Whitney U test (for non-normally distributed
data) to identify the significant dietary effects. Differences
were considered statistically significant when P,0·05 (all two-
sided). Statistical analyses were conducted with GraphPad
Prism version 5.01 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Animal growth and food intake
No diet-induced differences in animal growth and food intake
were observed before supplementation with scFOS: all rats
consumed the provided 16 g/d as intended. However, animal
growth was affected by the different diets during scFOS sup-
plementation. Rats from the HCaLP group gained less weight
during supplementation with scFOS than those from the
HCaMP group (Fig. 1(a), P¼0·006). The other dietary groups
did not differ with respect to growth. The results for food
intake were similar: HCaLP-fed rats had a more decreased
food consumption than those fed the HCaMP diet during
scFOS supplementation (Fig. 1(b), P¼0·02).
Faecal baseline characteristics before short-chain
fructo-oligosaccharide supplementation
Daily output of faeces, based on dry weight, was increased
due to Ca supplementation (Table 1; P,0·0001), in accord-
ance with previous work(7,14). To check whether the dietary
interventions indeed affected the baseline Ca and phosphate
levels in the colonic lumen before scFOS supplementation,
we measured total Ca and P in the faeces (Table 1). Indeed,
Ca concentration was clearly higher in the Ca-supplemented
group (HCaHP: P,0·0001) compared with levels in the
LCaMP group. P levels in the faeces also corresponded well
with the dietary intervention. Faecal P was increased in rats
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Fig. 1. Effect of dietary calcium and phosphate on (a) body-weight gain and (b) food intake during short-chain fructo-oligosaccharide (scFOS) supplementation
(n 10). (a) Values are mean change in body weight at the end of the experiment (experimental day 20) compared with body weight just before the start of scFOS
supplementation (experimental day 9), with standard errors represented by vertical bars. * Mean values were significantly different from those of rats on a high-
calcium, medium-phosphate (HCaMP) diet (P¼0·006). (b) Values are mean cumulative change in food intake during scFOS supplementation compared with food
consumption before scFOS supplementation, with standard errors represented by vertical bars. * Mean values were significantly different from those of rats on a
HCaMP diet (P¼0·02). LCaMP, low-calcium, medium-phosphate; HCaHP, high-calcium, high-phosphate; HCaLP, high-calcium, low-phosphate.
Table 1. Effect of diet on faecal baseline characteristics before short-chain fructo-oligosaccharide supplementation
(Mean values with their standard errors)
LCaMP HCaHP HCaMP HCaLP
Mean SEM Mean SEM Mean SEM Mean SEM
Faecal dry weight (g/d) 1·02 0·02 1·31* 0·02 1·37 0·03 1·38 0·04
Ca excretion (mmol/d) 78 10 1051* 34 1098 19 887† 19
P excretion (mmol/d) 65 6 733* 21 350‡ 17 116† 8
LCaMP, low-ca, medium-phosphate; HCaHP, high-ca, high-phosphate; HCaMP, high-ca, medium-phosphate; HCaLP, high-ca, low-phosphate.
* Mean values were significantly different from those of rats on the LCaMP diet (P,0·0001).
† Mean values were significantly different from those of rats on the HCaMP diet (P,0·0001).
‡ Mean values were significantly different from those of rats on the HCaHP diet (P,0·0001).
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fed the HCaHP diet (P,0·0001) compared with those fed the
LCaMP diet. As expected, the concentration of P was
decreased in the HCaMP group (P,0·0001) compared with
the HCaHP group, and further diminished in rats fed the
HCaLP diet compared with the HCaMP group (P,0·0001).
Subsequently, the buffering capacity of these faecal samples
was determined to evaluate whether the diets affected this
capacity as hypothesised. Luminal buffering capacity was
higher in the HCaHP group (P,0·0001) in comparison with
rats fed the LCaMP diet (Fig. 2). Also as expected, buffering
capacity of the faeces was lower in rats on the HCaMP diet
(P¼0·01) compared with those on the HCaHP diet. And
indeed, buffering capacity was further decreased in rats fed
the HCaLP diet (P¼0·04) compared with those fed the
HCaMP diet. The results of the faecal buffering capacity
measurements after scFOS supplementation showed similar
dietary effects (data not shown).
The effect of dietary calcium and phosphate on intestinal
permeability
The main outcome of the present study is the dietary effect on
intestinal permeability, measured by urinary CrEDTA
excretion. Dietary Ca already decreased intestinal permeability
before the colon was challenged with scFOS; however, this
was not the case in rats fed the HCaLP diet. Urinary CrEDTA
expressed as a percentage of dietary intake was 5·9 (SEM
0·5) in the LCaMP group, 4·2 (SEM 0·3) in the HCaHP group
(P¼0·007, compared with LCaMP), 4·1 (SEM 0·2) in the
HCaMP group and 6·5 (SEM 0·5) in the HCaLP group
(P¼0·0002, compared with HCaMP). Importantly, after
scFOS supplementation, dietary Ca only prevented the fer-
mentation-induced increase in intestinal permeability when
rats were fed a diet containing high or medium levels of phos-
phate (HCaHP, P¼0·049 compared with LCaMP; Fig. 3), but
not when rats were fed the low-phosphate diet (P¼0·04 com-
pared with HCaMP; Fig. 3).
Dietary effects on caecal lactate levels
To investigate whether fermentation of scFOS is disturbed due
to acid accumulation, lactate was quantified in caecal con-
tents(26,27). Ca supplementation in a high-phosphate back-
ground (HCaHP) resulted in significantly lower lactate levels
in caecal contents compared with rats fed the LCaMP diet
(P¼0·006; Fig. 4(a)). Lactate levels were similar in the
HCaMP group compared with rats fed the HCaHP diet,
while these levels were higher in rats on the HCaLP diet
compared with the HCaMP group (P¼0·01; Fig. 4(a)).
Interestingly, lactate levels are correlated with the colonic
permeability results (Spearman’s r 0·45, P¼0·006). The dietary
effects on caecal pH show comparable results, since the pH in
the caecum of the HCaHP group was significantly higher than
the pH of the caecal contents of LCaMP-fed rats (6·9 (SEM 0·2)
v. 5·8 (SEM 0·1), respectively, P¼0·0008). No differences in
caecal pH were observed in the other dietary groups
(HCaMP, 7·2 (SEM 0·2); HCaLP, 6·8 (SEM 0·3)).
Dietary calcium and phosphate influence luminal
cytotoxicity
To investigate whether faecal water cytotoxicity, reflecting
colonic mucosal exposure to luminal irritants, plays a role in
the dietary effects on colonic permeability, the cytotoxicity
assay was performed with faecal water from the period after
scFOS supplementation. Cytotoxic activity of faecal water
was lower in rats fed the HCaHP diet (P¼0·006; Fig. 4(b))
compared with those fed on the LCaMP diet. In HCaLP-fed
rats, luminal cytotoxicity was increased compared with rats
fed the HCaMP diet (P¼0·01; Fig. 4(b)).
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Fig. 2. Effect of dietary calcium and phosphate on faecal buffering capacity
before short-chain fructo-oligosaccharide supplementation (n 10). Values are
means of triplicate measurements of pooled faeces (15 % dry weight), with
standard errors represented by vertical bars. Buffering capacity is calculated
as the quantities of hydrochloric acid (in mmol) required to decrease the pH
to 5. * Mean values were significantly different from those of rats on a high-
calcium, medium-phosphate (HCaMP) diet (P¼0·04). † Mean values were
significantly different from those of rats on a low-calcium, medium-phosphate
(LCaMP) diet (P,0·0001). ‡ Mean values were significantly different from
those of rats on a high-calcium, high-phosphate (HCaHP) diet (P¼0·01).
HCaLP, high-calcium, low-phosphate.
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Fig. 3. Effect of dietary calcium and phosphate on urinary chromium-EDTA
(CrEDTA) excretion, a marker for intestinal paracellular permeability, after
short-chain fructo-oligosaccharide (scFOS) supplementation (n 10). Values
are mean change in urinary CrEDTA excretion (% of intake) at the end of the
experiment (experimental day 20) compared with urinary CrEDTA excretion
(% of intake) before the start of scFOS supplementation (experimental
day 10), with standard errors represented by vertical bars. * Mean values
were significantly different from those of rats on a high-calcium, medium-
phosphate (HCaMP) diet (P¼0·04). † Mean values were significantly different
from those of rats on a low-calcium, medium-phosphate (LCaMP) diet
(P¼0·049). HCaHP, high-calcium, high-phosphate; HCaLP, high-calcium,
low-phosphate.
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Discussion
The present study shows that the beneficial effect of dietary Ca
on colonic permeability is impaired if dietary phosphate levels
are low. If dietary phosphate is sufficient, Ca decreases colonic
permeability, which is associated with an increase in luminal
buffering capacity. The protective effect of Ca on permeability
is also related to lower caecal lactate levels and a decreased
faecal cytotoxicity during scFOS supplementation. Besides
the abrogation of the protective effect of a high-Ca diet on
colonic permeability, low phosphate intake also adversely
affected food intake and animal weight after scFOS
supplementation.
The protective effect of dietary Ca on intestinal permeability
has been shown consistently in several studies using different
animal models. It is of relevance that Ca can improve intestinal
permeability both in a healthy situation(13) and during intesti-
nal infection(9) and colitis development(12). In the latter two
studies, the prevention of an increase in intestinal permeability
by Ca was associated with an enhanced resistance to the
development of intestinal disease. The present study empha-
sises the potential of Ca to decrease intestinal permeability
in a healthy condition; however, it also shows that dietary
phosphate intake has to be taken into account.
Since it is still unknown how Ca exerts its beneficial effect
on gut permeability, we aimed to investigate whether a cal-
cium-phosphate-induced increase in luminal buffering
capacity is involved. By acidifying the colon with scFOS in
the present study, the capacity to buffer the intestinal contents
becomes even more important. Interestingly, scFOS induce an
increase in intestinal permeability(13,28), but it is not proven
that this is associated with luminal acidification caused by
scFOS, although this seems likely. There are indications
from in vitro studies that the extracellular pH is important
for paracellular permeability(29–31). We aimed to show exper-
imental support for the hypothesised effect that the luminal
buffering capacity affects intestinal permeability, and is part
of the protective effect of Ca, in a situation of enhanced
luminal acidification through scFOS in the diet. Indeed, the
protective effect of Ca on colonic permeability was impaired
if dietary phosphate levels were low, and this effect was
associated with a decrease in luminal buffering capacity.
Fermentation already starts in the caecum of rats; however,
as has been described earlier(13), it clearly continues in the
rat colon, showing the relevance of faecal sampling. There-
fore, the similarity of the effects of scFOS in both the
caecum and colon of rats and human colonic fermentation
supports the use of the rat as an appropriate model to study
possible subsequent permeability alterations. Moreover, intes-
tinal pH values(32) and faecal phosphate levels(33) are similar
in rats and humans, indicating that diet-modulated buffering
capacity in the colon is comparable between these species.
These results show that the protective effect of dietary Ca is
at least partly due to its role as a carrier of phosphate into
the colon. Subsequently, phosphate is responsible for the
increase in colonic buffering capacity.
Ca supplementation in combination with high or medium
dietary phosphate prevented a fructo-oligosaccharide-induced
accumulation of lactate in the caecal contents, which was associ-
ated with the decrease in intestinal permeability. During rapid
fermentation of easily fermentable carbohydrates, lactate
accumulation can occur when micro-organisms that utilise
lactate are inhibited(26). These micro-organisms might be
inhibited by an acidic pH due to a compromised buffering
capacity. It is therefore likely that alterations in microbiota
composition or activity are responsible for the changes in
caecal lactate levels. Interestingly, intestinal micro-organisms,
for example Escherichia coli, are able to induce an increase in
intestinal permeability(34). Therefore, buffering capacity might
also indirectly influence intestinal permeability by modulating
the gut microbiota.
An alternative explanation for the dietary effects on intesti-
nal permeability, besides modulation of luminal buffering
capacity, might be the influence of supplemental Ca on lumi-
nal cytotoxicity. The present study demonstrates that a lack of
phosphate counteracts the inhibiting effect of Ca on cytotox-
icity(35). Clearly, both Ca and phosphate are needed to precipi-
tate cytotoxic components(35), which can irritate the intestinal
epithelium(36) and subsequently modify permeability.
Modulation of luminal cytotoxicity might also change the
microbiota, which can thereby exert an influence on epithelial
integrity(34). We have shown earlier that Ca affects the gut
microbiota(9,13,37). The results of the present study suggest
that phosphate is necessary for the effect of Ca, but not
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Fig. 4. Effect of dietary calcium and phosphate on (a) caecal lactate levels and (b) luminal cytotoxicity after short-chain fructo-oligosaccharide supplementation
(n 10). Values are means of caecal lactate levels quantified by using a colorimetric enzymatic kit, and for luminal cytotoxicity determined with an erythrocyte
bioassay, with standard errors represented by vertical bars. * Mean values were significantly different from those of rats on a high-calcium, medium-phosphate
(HCaMP) diet (P¼0·01). † Mean values were significantly different from those of rats on a low-calcium, medium-phosphate (LCaMP) diet (P¼0·006). HCaHP,
high-calcium, high-phosphate; HCaLP, high-calcium, low-phosphate.
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determinative, i.e. as long as phosphate intake is sufficient
($70 mmol/kg diet), the effect of Ca is not dependent on
phosphate.
Impairment of the gut mucosal barrier by scFOS has
been shown earlier in association with a decreased resistance
to intestinal infection(19,28,38). These harmful effects were
decreased when Ca was supplemented to the diet(8). The pre-
sent study emphasises again that it is important to take care of
a sufficient Ca intake when non-digestible carbohydrates are
consumed. Furthermore, the present results show that dietary
phosphate levels should also be taken into consideration. The
adverse effects of low phosphate intake on food consumption
and animal weight, which emerged during scFOS supplemen-
tation, support this observation.
The Ca and phosphate content of the rat diets in the present
study is nutritionally relevant for the human diet. In general,
human dietary Ca intake in the Western world ranges from
600 to 1100 mg daily(39). The Ca concentration of the low-Ca
diet corresponds to a daily Ca intake of 600 mg in humans,
while the Ca-supplemented diets provided more than the gen-
eral habitual dietary Ca intake (comparable to 2·4 g daily),
which is not unrealistic when taking Ca supplements(12).
In addition, the animal diets contained phosphate levels of
approximately 160 mmol/kg diet (high-phosphate), 70 mmol/
kg diet (medium-phosphate) and 35 mmol/kg diet (low-
phosphate), which are in the range of human intake of
about 40 mmol phosphate daily (80 mmol/kg diet), assuming
that humans have a daily dry food intake of about 500 g(39).
In conclusion, the present study shows that the protective
effect of dietary Ca on intestinal permeability is impaired if
phosphate levels are low, and this is associated with the
effects on luminal buffering capacity. This is particularly
important when consuming a diet with non-digestible and
rapidly fermentable carbohydrates such as scFOS. So, phos-
phate levels should be sufficient in the diet to accomplish
the protective effect of Ca on intestinal permeability. It
cannot be excluded that changes in luminal buffering capacity
also indirectly modulate intestinal permeability, for example,
by the effects on the intestinal microbiota. The present study
encourages follow-up studies, particularly in human subjects,
to further explore and apply the potential to modulate gut
barrier integrity by relatively simple dietary interventions.
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